Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Stromal Tumors (GIST)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01440959
What this trial is testing

Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 30
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Large-scale testing (Phase 3)Study completedNCT03465722
What this trial is testing

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Who this might be right for
GIST
Blueprint Medicines Corporation 476
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00769782
What this trial is testing

Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal TumorMetastatic Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 6
Not applicableStudy completedNCT06038552
What this trial is testing

Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

Who this might be right for
GIST, MalignantLiver Metastases
First Affiliated Hospital, Sun Yat-Sen University 238
Early research (Phase 1)Study completedNCT01743300
What this trial is testing

The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients

Who this might be right for
Healthy
Leiden University Medical Center 15
Large-scale testing (Phase 3)Ended earlyNCT00688766
What this trial is testing

Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Infinity Pharmaceuticals, Inc. 47
Not applicableStudy completedNCT04343456
What this trial is testing

Salvage Surgery for Patients With Metastatic GIST With Rego

Who this might be right for
Gastrointestinal Stromal TumorsMetastasisDisease Progression
Chang Gung Memorial Hospital 41
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT02342600
What this trial is testing

SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)

Who this might be right for
Gastrointestinal Stromal Tumors
Sarcoma Alliance for Research through Collaboration
Testing effectiveness (Phase 2)Looking for participantsNCT07689201
What this trial is testing

Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT02607332
What this trial is testing

Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 25
Early research (Phase 1)Study completedNCT00513851
What this trial is testing

Phase 1 Study of OSI-930 in Cancer Patients

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Study completedNCT04258956
What this trial is testing

Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy

Who this might be right for
Gastrointestinal Stromal Tumors
Maria Sklodowska-Curie National Research Institute of Oncology 58
Post-approval studies (Phase 4)Ended earlyNCT00461929
What this trial is testing

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Cell TumorsChromosome Abnormality
University Health Network, Toronto 68
Testing effectiveness (Phase 2)UnknownNCT03171389
What this trial is testing

POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST

Who this might be right for
GIST, MalignantKIT Exon 13 MutationKIT Gene Mutation
Sebastian Bauer 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT04595747
What this trial is testing

Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Locally Advanced Gastrointestinal Stromal TumorLocally Advanced SarcomaMetastatic Gastrointestinal Stromal Tumor+5 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00359333
What this trial is testing

Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST

Who this might be right for
SarcomaMalignant Gastrointestinal Stromal Tumor
National Health Research Institutes, Taiwan 58
Testing effectiveness (Phase 2)UnknownNCT00290485
What this trial is testing

Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Maisonneuve-Rosemont Hospital 50
Next Page